Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 13000 participants.
Also called NCT04962451
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 13,000 participants
- Registry
-
NCT04962451
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04962451. Randomized; double masking; primary purpose treatment. Start 2017-09-01 (actual); primary completion 2019-09-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke
- Condition
- Cerebrovascular Accident
- Condition
- Cerebrovascular Accident, Acute
- Intervention (Drug)
- ticagrelor + ASA
- Intervention (Drug)
- Placebo+ASA
- Lead sponsor
- Peking University Third Hospital
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct04962451- Content hash
51a22ea67b74f22cd2715192357731f6a04688a6e86603a63b99c1762dc1e5b9